Oelschlaegel U, Winter S, Sockel K, Epp K, Schadt J, Röhnert MA, et al. MDS-PB13 score—blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed myelodysplastic neoplasms. Leukemia. 2024;38:446–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hibbs S. This is going to hurt: revisiting the patient experience of bone marrow biopsies. Hemasphere. 2022;6:e710.

Article  PubMed  PubMed Central  Google Scholar 

Buckstein R, Jang K, Friedlich J, Zhang L, Reis M, Chesney A, et al. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows. Leuk Res. 2009;33:1313–8.

Article  PubMed  Google Scholar 

Oster HS, Crouch S, Smith A, Yu G, Abu Shrkihe B, Baruch S, et al. A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS. Blood Adv. 2021;5:3066–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raskovalova T, Berger MG, Jacob MC, Park S, Campos L, Aanei CM, et al. Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study. Haematologica. 2019;104:2382–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raskovalova T, Jacob MC, Bulabois CE, Mariette C, Scheffen L, Park S, et al. Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression for ruling out myelodysplastic syndromes: a prospective validation study. Ann Hematol. 2021;100:1149–58.

Article  CAS  PubMed  Google Scholar